Abstract-The responsiveness to IL-4 with and without costimulation with anti-IgM antibodies or phorbolester was studied in 35 cases of low grade non-Hodgkin Iymphoma by analyzing enhancement of CD23 and HLA dass li expression. The predominant phenotype responds directly to IL-4. Separate differentiation states can be distinguished according to coordinate or differential upregulation of CD23 and HLA dass II molecules by IL-4 alone, and differences in responsiveness to anti-IgM antibodies. A particular subgroup of B-lymphoma cells defines a separate stage of B-eeil differentiation. They fail to express high affinity binding sites for IL-4 and accordingly do not respond to IL-4-mediated signals. Cross-linking membrane lgM receptors or direct activation of protein kinase C via phorbolester induces IL-4 receptor expression and subsequent IL-4 reactivity.
JNTRODUCTION
THERE is mueh evidenee that important signals required in B-eeil aetivation involve slg cross-linking whieh leads to and is dependent upon subsequent aetivation of PKC [ 1] . Another signalling system implieated in early B-eeil aetivation processes, using different, not yet clearly understood seeond messenger systems, is IL-4 [2] [3] [4] . The expression of funetional IL-4 reeeptors without a requirement for prior aetivation is a hallmark of immunoeompetent resting B eells [5, 6] . This finding, in addition to the definition of type 2 T-helper cells which seerete large amounts of IL-4 [7] , has been taken as evidenee that IL-4 may play an important role in the early events of B-eeil activation, and may be even part of the eognate Thelper signal. The slg as weil as the IL-4-induced signal caseade result in activation of genes whose produets seem to be involved in regulation of B-eeil proliferation [8, 9] or T-eell, B-eell eooperation [10] [11] [12] [13] [14] . Both signals Iead to upregulation ofMHC class li expression on B eells [6, 15}. IL-4 induees enhaneed CD23 [5, 16] expression whereas slg eross-linking fails to do so. However, they are conneeted in that eostimulation with anti-Ig and IL-4 Ieads to hyperinduetion of CD23 expression [5] .
Correspondence: Hans-Peter Tony, Medizinische Poliklinik der Universität, Klinikstr. 8, 8700Würzburg, F.R.G. 911 Lymphocytic Iymphoma B cells are thought tobe in a developmental stage closely related to immunocompetent, resting B cells [ 17] . Therefore we addressed the question how low grade NHL B eells ean respond to the two B-eeil aetivation pathways indueed either by eross-linking of the slg receptor or signals generated by IL-4. This is important for judging how a B-eeil tumor whieh is expanded in most eompartments ofthe immune system may interact with the normal immune cells. Functional distinctions among B-cell tumors may be representative for normal B cells in partieular stages of aetivation or differentiation. Different B-eeil tu mors can be valuable tools for dissecting the signal cascades required for HLA dass II and CD23 expression and the cooperation between IL-4 and slg mediated signals.
MATERIALSAND METHODS
Reagents. Recombinant human IL-4 was purchased from Genzyme (IC Cemikalien, Munich, F.R.G.). Soluble goat F(ab') 2 -anti-IgM antiborlies were obtained from Jackson Laboratories (Dianova, Hamburg, F.R.G.), phorbolmyristate-acetate (PMA). from Sigma (Deisenhofen, F.R.G.). Monoclonal antibodies, phycoerythrin (PE)-and ftuorescein-iso-thyocyanate (FITC)-labeled, were used: Leu12 (CD19), Leul (CD5), HLA-DR, HLA-DQ, Leu-M3 (CD14), Leullc (CD16), Leul9 (CD56) (Becton-Dickinson, Heidelberg, F.R.G.) and 1088 (CD23) (Immunotech, Dianova, F.R.G.). Purified mAb against lgM, kappa-and lambda-light chains ( Coulter, Krefeld, F. R. G.) were developed with a FITC-labeled F(ab'h-fragment of rabbit anti-mouse IgG (Jackson, Oianova).
Lymphoma cells. Thirty-five patients were diagnosed as having a leukemic B-eeil Iymphoma of low malignancy, mainly CLL, immunocytoma and centrocytic Iymphoma (case 23, 33, 35) . Cell surface phenotyping revealed a typical staining pattern (18] : CD19, CD5, HLA dass lipositive with low expression of a light chain restricted surface lgM. Only case 22, 23, 31 and 35 stained negative for the CD5 antigen. Even though most cases were also CD23-positive. This antigen showed a considerable variability in staining intensity. The cell size distribution of the Iymphoma cells showed most of them only slightly larger than low density peripheral blood cells as judged by forward scatter analysis (Table lc) . No patient received any form of specific therapy.
Cell preparation and culture conditions. Mononuclear cells (PBL) were isolated from heparinized blood (Heparin NOVO, Novo Industry, Mainz, F.R.G.) on Ficoll-Hypaque (Pharmacia, Freiburg. F.R.G.) density gradients. Part of the cells were cryopreserved using a programmable cell freezer (Sylab, Austria). Peripheral Iymphoma cells were T-depleted by rosetting with AET-treated sheep erythrocytes or anti-CD2, anti-CD4 and anti-CD8 coupled ox erythrocytes [19] . This depleted also most of NK cells and activated monocytes. FACS analysis revealed ~98% CD19-positive cells. Less than 1% stained with either Tcell-specific (CD3), monocyte-specific (CD14) or NKspecific (CD16, CD56) antibodies. Normal control B cells were purified from a spieen of a donor without hematological disease. T cells, NK cells and activated monocytes were depleted by rosetting with anti-CD2, anti-CD4 and anti-C08 coupled ox erythrocytes. Monocytes were further depleted by avidin-coupled magnetic beads (Dynabeads M-280, Dianova) using biotinylated MY4 (CD14, Coulter) antibodies. This gave 95-98% CD19-positive cells. Purified B cells were cultured at 10 6 /ml in RPMI 1640, containing 10% fetal calf serum (Gibco, New York) in 24-well tissue culture plates (Falcon, Heidelberg, F.R.G.).
Surface marker analysis. FACS analysiswas done after staining with monoclonal antiborlies using a F ACscan (Becton-Dickinson, Mountain View. CA, U.S.A.). Ten thousand viable cells were analyzed using forward/ sidescatter gating.
Determination of 1 L-4 receptors.
Recombinant IL~4 was radiolabeled using the enzymobead radioiodination reagent (Bio Rad, München, F.R.G.) [20] . Equilibrium binding of 125 1-labeled IL-4 (1 25 1-IL-4) to human B-lymphoma cells was done according to Cabrillat [21] : purified Iymphoma cells (10 6 ) were washed and suspended in 200 f.ll RPMI, containing 2% bovine serum albumin (BS1) and 0.2% sodium azide, with various concentrations of 1 1-IL-4 either in the presence or absence of a 6000-fold excess of cold IL-4. After incubation for 2 h at 4°C, cells were washed twice. Cell bound 125 1-IL-4 was separated from free I25J-IL-4 by centrifugation through 200 f.ll silicon oil. The number of binding sites per cell was calculated from the linear portion of Scatchard plots.
RESULTS
Tables 1 a--c give an overview of the studied Iymphoma cells. The data are presented as values of mean ftuorescence intensity for the respective directly labeled mAb. We think it important to provide the raw data for the different stimuli, since it reveals the heterogeneity in baseline expression of CD23 and HLA class II and more importantly in responsiveness between the different Iymphoma B cells.
Responsiveness to slg and P MA -mediated signals
We analyzed the expression of HLA class II, CD23 molecules and increase in cell size upon stimulation with soluble F(ab'h-anti-IgM antibodies or direct activation of PKC via PMA. A maximum response was usually seen between 10 and 30 ~g/ml F(ab'hanti-IgM and 1-5 ng/ml PMA, after a culture period of 30-40 h (not shown). As judged from the FACS staining profiles, positive responses incJuded usually more than 80% of the cells.
In contrast to normal control spienie B cells only 14 out of 35lymphoma cases showed a reproducible, significant increase of HLA dass II expression in response to soluble F(ab') 2 -anti-IgM antiborlies (Table lb: cases 22-24. 26-35) . The reactivity is not related to the intensity of basal HLA dass II expression. An appreciable cell enlargement is only seen in three cases ( patients 33-35) upon slg crosslinking (Table 1c) . Apart from these, most of the other studied Iymphoma cells increased their cell size upon PMA stimulation but failed to do so with F(ab'h-anti-IgM antibodies (data not shown). However, the majority of cases respond to PMA with an increase in HLA dass Ilexpression (Table 1b) . Thus the events of the intracellular signaHing cascade distal to PKC activation seem to function in most Iymphoma cases.
Soluble F(ab'h-anti-IgM antiborlies induce no appreciable increase in CD23 expression on normal or on the studied Iymphoma cells, whereas PMA is able to induce CD23 on the same cells (Table 1) .
Responsiveness to I L-4-mediated signals
Since we could enhance HLA class li and CD23 expression in all studied Iymphoma cells (via PMA or anti-Ig), we asked if the IL-4-induced signal cascade is also operating in the Iymphoma cells and results in the expression of these particular gene products. Therefore we measured HLA class li and CD23 expression upon Stimulation with IL-4.
Tables la and b show that 31 out of 35 Iymphomas are responsive to IL-4 without prior activation. IL-4 can upregulate the expression of CD23 or HLA class 11 molecules. In most cases both antigens could be coordinately upregulated similar to normal control B cells (NC, Tables 1a, b). We did not observe any dose or kinetic differences between the Iymphomas. Purified B cells were cultured at 10 6 cells/ml for 40 h. Expression of CD23 was determined by ftow cytometry. The Iymphoma cases were grouped for reproducible responsiveness to anti-IgM antibodies. Cases 1-21 show no anti-Ig reactivity, whereas cases 22-35 do respond. Cases 33-35 are separated from the latter group because of lacking IL-4 responsiveness.
* Mean fluorescence intensity. linear scale.
t F(ab')z-anti-IgM 10 ~g/ml. :j: riL--4 100 U/ml. § PMA 3 ng/ml.
II Not done.
~ Purified B cells of a healthy control person.
The maximum effect is reached between 10 and 100 V /ml IL-4 after a 32-40 h culture period ( data not shown). We never saw a significant size increase upon IL-4 in normal control B cells or in Iymphoma cells (Table lc) . However there is heterogeneity in the response pattern to IL-4. Most cases upregulate CD23 and HLA dass II molecules coordinately, but five out of 35 cases show a dissociation in that they are consistently induced for elevated HLA dass li expression, while failing to upregulate CD23 ( [33] [34] [35] show no response to IL-4 at all, neither for HLA dass II nor for CD23 expression, even though both antigens can be upregulated in these cells by F(ab')2-anti-IgM antibodies or PMA, respectively (Tables la, b) .
Enhancement of JL-4-induced CD23 expression upon costimulation with anti-lg or PMA
It has been reported that costimulation with insolubilized anti-IgM antibodies and IL~4 leads to Binding experiments were done as shown in Fig. 3 . Numbers of IL-4 receptors were caJculated from Scatchard plot analysis. Lymphoma cells were depleted ofT cells and were 98% CD19-positive.
• F(ab')2-anti-I~M was used at 10 J.Lg/ml. t PMA at 3 ngjml.
/nduction of IL-4 reactivity in IL-4 non-reactive Iymphoma cells
Three out of 35 Iymphoma cases (Nos 33-35), which stained negative for CD23, repeatedly failed to respond to IL-4 as judged by enhancement of HLA dass II expression (Fig. 1, case 33 ) or CD23 expression (Table la) . However, cross-linking slg via F(ab') 2 -anti-IgM antiborlies induces expression of HLA class II molecuJes with coordinate upregulation of all three subgroups HLA-DR, -DQ and -DP (Fig.  1) . CD23 expression can be induced by PMA. Costimulation of these cells with F(ab'h-anti-IgM antiborlies and IL-4 result in high expression of CD23 even though both stimuli alone failed to do so (Table  la) .
We then analyzed the time sequence of the two required signals in these Iymphoma cells. 
Expression and induction of /L-4 receptors in Iymphoma B cells
The Iack of IL-4 responsiveness of cases 33-35 may be due to a failure of IL-4 receptor expression or may indicate a requirement for IL-4 receptor activation for signal transmission. We therefore determined the number of IL-4 receptors on the Iymphoma cells by binding of radiolabeled IL-4. Figure 3 illustrates typical equilibrium binding data for 125 1-IL-4 to a IL-4 responsive Iymphoma (case 1, Table 1b ). Scatchard plot analysis yielded 750-800 specific binding sites per cell.
Recently it has been shown that insolubilized antilgM antibodies upregulate the number of high affinity IL-4 receptors on normal human B cells [22] . Sirnilady we demoostrate elevated numbers of IL-4 receptors after PMA Stimulation. As shown in Table 2 (Table 2 ). However, after stimulation of Iymphoma case 33 for 18 h with either soluble F(ab'h-anti-IgM or PMA, we can detect 180 and 190 IL-4 receptors per cell, respectively. This parallels the induction of IL-4 reactivity by these stimuli (Fig. 2) . These data indicate that the IL- [8, 9, 24, [27] [28] [29] [30] and T celi-B cell cooperation [10--14] .
To avoid phenotypes produced by in vitro selection of a cellline, we used only cells freshly isolated from the peripheral blood. The Iymphoma cases were not selected for reactivity in our activation system. They were studied in the order of their presentation and were required only to have a peripheral Iymphoma cell count of over 10 000 cells/mm 3 • Our results indicate a remarkable heterogeneity in responsiveness to the employed signals which could not be related to the phenotype of the Iymphoma cells. The majority of the Iymphomas respond to IL-4 by coordinate upregulation of CD23 and HLA dass II molecules as has been shown for some Burkitt Iymphoma celllines (26] . Thus, like normal tonsillar [5] or spienie B cells (NC Tables la-c), they express functional IL-4 receptors without a requirement for prior activation. The pattern of responsiveness is not dependent from the source of B cells, since we have not observed fundamental differences between B cells isolated from the blood, tonsils or spieen in healthy persons [unpublished] .
The upregulation of CD23 can be shown in Iymphoma cells which express low amounts of CD23 as weH as in cells which already stain for CD23. Accordingly, high affinity receptors can be demonstrated by binding of radiolabeled IL-4. The various Iymphoma cells express between 200 and 900 IL-4 receptors per cell (Fig. 3 , Table 2 and (T. Lebrobeeher, unpublished data]) which corresponds weil to the nurober of IL-4 receptors on normal, resting B cells [22] . Therefore most neoplastic B cells resemble normal, resting immunocompetent B ceiJs, which may argue that these Iymphoma cells represent a dosely-related developmental stage.
CD23 expression has been used to define developmental B-cell stages, since it is not expressed on immature B cells and is lost after isotype switching of mature B cells [31] [32] [33] . This developmental analysis has been extended by analyzing the dissociation of the IL-4 response as measured by CD23 or HLA dass II expression. Waldschmidt and coworkers have shown that immature, murine lgM+ /IgD+ B cells respond to IL-4 by enhanced HLA class II expression, but fail to upregulate CD23. These authors even suggest that this response pattern would better define the self-renewing "sister-B-celllineage" [32] . The Iack of coordinated expression of CD23 and HLA dass II molecules can also be seen in a group of the Iymphomas which we studied. For example, cases 19-21, 30, 31 (Tables 1a-c) respond quite weil with elevated HLA dass II expression in response to IL-4. However, we could not see CD23 induction with IL-4 in these Iymphoma cells even though CD23 could be upregulated with PMA. This is independent of the IL-4 dose employed ( data not shown). These types of Iymphoma cells may allow the dissection of the signal cascades required for MHC dass II and CD23 expression.
slg signalling results at least in part from Stimulation of inositol phospholipid breakdown and activation of PKC (34) (35) (36) . Therefore phorbolesters can be used to "shortcut" the sig-mediated signal and substitute for anti-Ig antiborlies in certain activation events [37J. Accordingly, PMA did induce HLA dass II molecules and acted, similar to soluble F( ab'hanti-IgM in normal spienie B cells, to enhance responsiveness to IL-4 as indicated by hyperinduction of CD23 in essentially ali the Iymphomas studied (Tables la-c) . This is probably due to enhanced IL-4 receptor expression, which we demonstrated in these Iymphomas in response to PMA (Table 2) .
However, PMA displays an additional signal quality in relation to anti-IgM antiborlies since PMA alone Ieads in normal as weil as in the studied Iymphoma cells to enhanced CD23 expression whereas soluble F(ab'h-anti-IgM antiborlies regularly fail to do so (Tables la-c) . This is in centrast to a report by Ghaderi et a/. [38] who find in 8 out of 9 CLL cases a decreased CD23 expression upon TPA Stimulation. The difference may be related to the indirect rosetting technique used for measuring CD23 expression.
Three Iymphoma cases (Nos 33-35) did not show any reactivity to IL-4. This was not due to a defect in the machinery for the expression of HLA dass II or CD23 molecules, since HLA dass li expression was inducible by membrane Ig cross-linking and CD23 by PMA (Tables la. b ). In fact all three major HLA class II subclasses HLA-DR, -DQ and -DP could be upregulated in these cells by cross-linking slg (Fig. 1) .
Binding studies with iodinated IL-4 failed to demoostrate any specific binding, indicating a Iack of IL-4 receptor expression on cells of cases 33 and 34 {Table 2). However, signalling through slgM by soluble F(ab')ranti-IgM antiborlies induces specific IL-4 binding sites in a frequency usually found on resting normal B cells (22}. Also, direct activation of PKC via PMA resulted in expression of IL-4 receptors, pointing to the centrat role of PKC in the regulation ofiL-4 receptor expression. Parallel to the expression of ILA receptors on the cell surface we can demoostrate IL-4 responsiveness by analyzing subsequent CD23 expression. This is also reftected in the kinetic data showing that anti-Ig preactivated B cells increase CD23 expression following addition of IL-4 earlier as compared to B cells receiving the anti-Ig and IL-4 signals at the same time (Fig. 2) .
These experiments support the hypothesis that hyperinduction of CD23 upon concomitant anti-Ig and IL-4 signaHing is due to enhanced expression of IL-4 receptors following the slg-mediated signals, rather than receptor activation.
The IL-4 receptor-negative Iymphomas showed no distinctive phenotype of surface markers usually used for phenotyping B-eeil Iymphoma cells. In particular CDS expression did not distinguish them from the other B-eeil Iymphomas of low malignancy. However, all stained negative for CD23. They are infrequent in as much as we only found 3 in 35 studied cases. They seem to define a distinct differentiation stage of B cells because they not only Iack IL-4 receptors and responsiveness but show distinctive functional behavior. They respond weil upon slg cross-linking with cell size enlargement, HLA class li expression and expression of functional IL-4 receptors, features most low grade Iymphomas lack. Future studies will be required to show how they fit into the differentiation scheme of B cells and whether or not they correspond to a distinct, self-renewing Bcelllineage, which has been extensively characterized in the mouse system (39}.
